Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Naderi GH et al. – Although induction therapy with monoclonal antibodies may reduce the incidence of acute rejection episodes, graft and patient survival rates were unchanged compared with conventional therapies. Also, there were no significant differences between the results of induction therapy with basiliximab and daclizumab.

Related Articles

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09    Relevance Score: 70%

The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09    Relevance Score: 70%

ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09    Relevance Score: 70%

Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 69%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 69%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address